European Heart Journal Advance Access originally published online on January 20, 2009
European Heart Journal 2009 30(6):689-698; doi:10.1093/eurheartj/ehn537
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction
1 Department of Internal Medicine, University of Oulu, PO Box 5000 (Kajaanintie 50), 90014 Oulu, Finland
2 Gentofte University Hospital, Copenhagen, Denmark
3 Department of Internal Medicine, University of Kuopio, Kuopio, Finland
4 Department of Cardiology, University of Tampere, Tampere, Finland
5 Department of Internal Medicine, Hopital Citadelle, Liege, Belgium
6 Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland
7 Glostrup Hospital, Copenhagen, Denmark
8 St Antonious Hospital, Nieuwegein, The Netherlands
9 Department of Cardiology, Center for Arrhythmias, Ullevål University Hospital, Oslo, Norway
10 Medtronic Bakken Research Center, Maastricht, The Netherlands
Received 25 April 2008; revised 30 October 2008; accepted 6 November 2008; online publish-ahead-of-print 20 January 2009.
* Corresponding author. Tel: +358 8 315 4108, Fax: +358 8 315 5599, Email: heikki.huikuri{at}oulu.fi
Aims: To determine whether risk stratification tests can predict serious arrhythmic events after acute myocardial infarction (AMI) in patients with reduced left ventricular ejection fraction (LVEF
0.40).
Methods and results: A total of 5869 consecutive patients were screened in 10 European centres, and 312 patients (age 65 ± 11 years) with a mean LVEF of 31 ± 6% were included in the study. Heart rate variability/turbulence, ambient arrhythmias, signal-averaged electrocardiogram (SAECG), T-wave alternans, and programmed electrical stimulation (PES) were performed 6 weeks after AMI. The primary endpoint was ECG-documented ventricular fibrillation or symptomatic sustained ventricular tachycardia (VT). To document these arrhythmic events, the patients received an implantable ECG loop-recorder. There were 25 primary endpoints (8.0%) during the follow-up of 2 years. The strongest predictors of primary endpoint were measures of heart rate variability, e.g. hazard ratio (HR) for reduced very-low frequency component (<5.7 ln ms2) adjusted for clinical variables was 7.0 (95% CI: 2.4–20.3, P < 0.001). Induction of sustained monomorphic VT during PES (adjusted HR = 4.8, 95% CI, 1.7–13.4, P = 0.003) also predicted the primary endpoint.
Conclusion: Fatal or near-fatal arrhythmias can be predicted by many risk stratification methods, especially by heart rate variability, in patients with reduced LVEF after AMI.
Key Words: Sudden cardiac death Heart rate Variability Implantable cardioverter-defibrillator
Results of the cardiac arrhythmias and risk stratification after acute myocardial infarction study.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
U. J. O. Gang, C. Jons, R. M. Jorgensen, S. Z. Abildstrom, J. Haarbo, M. D. Messier, H. V. Huikuri, P. E. B. Thomsen, and on behalf of the CARISMA investigators Heart rhythm at the time of death documented by an implantable loop recorder Europace, February 1, 2010; 12(2): 254 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Madias Prediction of fatal or near fatal arrhythmias in patients with a depressed left ventricular function after an acute myocardial infarction Eur. Heart J., May 2, 2009; 30(10): 1288 - 1288. [Full Text] [PDF] |
||||

